                         SEQUENCE LISTING

<110>  Duke University
       Laskowitz, Daniel T.
       Mace, Brian
       Kolls, Bradley
 
<120>  REDUCING THE LIKELIHOOD OF EPILEPTOGENESIS

<130>  1175-3WO

<150>  US 62/450,693
<151>  2017-01-26

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  Consensus ApoE mimetic anti-inflammatory peptide sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa can be a hydrophobic amino acid or a positively charged amino
       acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa can be a hydrophobic amino acid, a positively charged amino 
       acid or a polar uncharged amino acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(4)
<223>  Xaa can be a positively charged amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa can be a hydrophobic amino acid or a positively charged amino
       acid

<400>  1

Xaa Xaa Xaa Xaa Xaa 
1               5   


<210>  2
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  2

Val Ser Arg Lys Arg 
1               5   


<210>  3
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  3

Val Ser Lys Arg Arg 
1               5   


<210>  4
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  4

Val Ser Arg Arg Arg 
1               5   


<210>  5
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  5

Val Ala Arg Lys Leu 
1               5   


<210>  6
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  6

Arg His Lys Lys Leu 
1               5   


<210>  7
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  7

Arg Ala Arg Arg Leu 
1               5   


<210>  8
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  8

Arg Ser Lys Lys Leu 
1               5   


<210>  9
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  9

Arg His Lys Arg Arg 
1               5   


<210>  10
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  10

Val Ala Arg Arg Leu 
1               5   


<210>  11
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  11

Val Ala Arg Arg Lys 
1               5   


<210>  12
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  12

Arg Ser Lys Arg Arg 
1               5   


<210>  13
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  Consensus ApoE mimetic anti-inflammatory peptide sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa can be an amino acid having a hydrophobic side chain or an 
       amino acid having a positively charged side chain

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa can be an amino acid having a hydrophobic side chain, an 
       amino acid having a positively charged side chain, or an amino 
       acid having a polar uncharged side chain

<220>
<221>  MISC_FEATURE
<222>  (3)..(4)
<223>  Xaa can be an amino acid having a charged side chain

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa can be an amino acid having a hydrophobic side chain or an 
       amino acid having a positively charged side chain

<220>
<221>  MISC_FEATURE
<222>  (6)..(9)
<223>  Xaa can be any amino acid and is optionally absent

<400>  13

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   


